Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Location: Switzerland, Zurich
Member count: 11-50
Total raised: $43.302355M
Founded date: 2019
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 05.10.2022 | - | $24M | - | venturelab... |
| 22.10.2020 | Seed | $16.746118... | - | finsmes.co... |
| 20.08.2019 | Seed | $2.556237M | - | finsmes.co... |
Mentions in press and media 25
| Date | Title | Description | Category | Author | Source |
| 04.11.2022 | The C-suit... | From intern to CEO Power ban... | Support | - | startuptic... |
| 05.10.2022 | Araris Bio... | Araris Biotech AG, a AU ZH, Sw... | Switzerlan... | - | finsmes.co... |
| 04.10.2022 | Araris Bio... | AU ZH, SWITZERLAND / October 4... | - | - | 4biocapita... |
| 04.10.2022 | Araris Bio... | /EIN News/ -- ZURICH, Switzerl... | - | - | einpresswi... |
| 04.10.2022 | Araris Bio... | ZURICH, Switzerland, Oct. 04, ... | - | - | globenewsw... |
| 04.10.2022 | Araris Bio... | Araris Biotech closes USD 24 m... | - | - | venturelab... |
| 04.10.2022 | Araris Bio... | Araris’ linker platform enab... | Financing | - | startuptic... |
| 08.02.2022 | 1100 Quadr... | Erst im vergangenen Jahr gab... | Expansion ... | - | startuptic... |
| 22.10.2020 | Araris Bio... | Araris Biotech raises CHF 15.2... | - | - | venturelab... |
| 22.10.2020 | 4BIO Capit... | · Dmitry Kuzmin, Managing Part... | - | - | 4biocapita... |
Show more